<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02209675</url>
  </required_header>
  <id_info>
    <org_study_id>tissue C4d</org_study_id>
    <nct_id>NCT02209675</nct_id>
  </id_info>
  <brief_title>Role of Tissue C4d in Differentiation Between Acut e Rejection and HCV Recurrence After Liver Transplantation</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Assessment of the role of tissue C4d complement fragments in liver biopsy as a new marker for
      differentiating between acute rejection and Hepatitis C (HCV) recurrence in recipients post
      living donor liver transplantation (LDLT) .As each condition require different treatment
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Role of tissue c4d assessment by immunohistchemistry in liver biopsy in differentiation
      between recurrent hepatitis c and rejection after liver transplantation.pathological
      examination may be sometimes confusing between the rejection and recurrent hepatitis C
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Actual">October 2014</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants who developed Acute cellular rejection after transplantation</measure>
    <time_frame>2 years</time_frame>
    <description>Assessment of the role of tissue C4d complement fragments in liver biopsy as a new marker for differentiating between acute rejection and hepatitis C recurrence in recipients post living donor liver transplantation (LDLT) .Each condition require different therapeutic management and the differentiation between them by ordinary methods is confusing due to overlapping pathological features between the rejection and recurrent hepatitis C desease</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Liver Disease</condition>
  <arm_group>
    <arm_group_label>patients with elevated liver enzymes</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients with elevated liver enzymes and/or hyperbilirubinemia post transplantation for hepatitis C virus related disease will have liver biopsy</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>liver biopsy</intervention_name>
    <description>C4d assessment by immunohistchemistry in liver biopsy</description>
    <arm_group_label>patients with elevated liver enzymes</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients transplanted for HCV related disease that are presented with elevated liver
             enzyme and/or hyperbilirubinemia and normal Abdominal Doppler ultrasound and Magnetic
             resonance cholangiography (MRCP).

        Exclusion Criteria:

          -  Evidence of other causes of elevated liver enzyme and/or hyperbilirubinemia as
             abnormal Abdominal Doppler ultrasound and/or Magnetic resonance cholangiography MRCP
             findings.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ain Shams center for organ transplant (ASCOT)</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>October 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 31, 2014</study_first_submitted>
  <study_first_submitted_qc>August 5, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 6, 2014</study_first_posted>
  <last_update_submitted>October 12, 2014</last_update_submitted>
  <last_update_submitted_qc>October 12, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 15, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Iman Fawzy Montasser</investigator_full_name>
    <investigator_title>Lecturer of tropical medicine , Ain Shams university</investigator_title>
  </responsible_party>
  <keyword>hepatitis C recurrence</keyword>
  <keyword>Rejection</keyword>
  <keyword>Liver Transplantation</keyword>
  <keyword>Liver biopsy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Extracts</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

